Aclaris Therapts (ACRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
Operating Expenses | 10,640 | 2,596 | 2,629 | 0 | 2,662 |
Operating Income | -10,640 | -2,596 | -2,629 | N/A | -2,662 |
Other Income | 8 | 2 | 6 | 0 | 5 |
Pre-tax Income | -10,632 | -2,594 | -2,623 | 0 | -2,657 |
Net Income Continuous | -10,632 | -2,594 | -2,623 | N/A | -2,657 |
Net Income | $-10,632 | $-2,594 | $-2,623 | $N/A | $-2,657 |
EPS Basic Total Ops | -5.12 | -1.52 | -1.61 | N/A | -1.75 |
EPS Basic Continuous Ops | -4.67 | -1.20 | -1.29 | N/A | -1.48 |
EPS Diluted Total Ops | -5.12 | -1.52 | -1.61 | N/A | -1.75 |
EPS Diluted Continuous Ops | -4.67 | -1.20 | -1.29 | N/A | -1.48 |
EBITDA(a) | $-10,608 | $-2,574 | $-2,626 | $N/A | $-2,662 |